CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sells, S. F.
Right arrow Articles by Rangnekar, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sells, S. F.
Right arrow Articles by Rangnekar, V. M.

Cell Growth & Differentiation, Vol 5, Issue 4 457-466, Copyright © 1994 by American Association of Cancer Research


ARTICLES

Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells

SF Sells, DP Wood Jr, SS Joshi-Barve, S Muthukumar, RJ Jacob, SA Crist, S Humphreys and VM Rangnekar
Department of Surgery, Nano Probe Laboratory, Markey Cancer Center, University of Kentucky, Lexington.

Prostate tissue is composed of both androgen-dependent and -independent cells. To identify the gene program induced by effectors of apoptosis in both of these cell types, we performed differential hybridization on a complementary DNA library prepared from an androgen-independent prostate cancer cell line, AT-3, exposed to ionomycin. Five distinct complementary DNAs representing ionomycin-inducible genes, designated prostate apoptosis response (par) -1, -2, -3, -4, and -5, were identified. Nucleotide sequencing identified par-1 as the rat homologue of a serum- and oxidative stress-inducible gene, 3CH134/erp/CL100; par-2 as the injury-inducible gene HB-EGF encoding a heparin-binding epidermal growth factor-like growth factor; par-3 as the serum-inducible gene cyr-61; whereas par-4 and par-5 were novel, as judged by a GenBank search. par-1, -3, -4, and -5 were also induced in rat ventral prostate following castration, which causes androgen ablation, leading to apoptosis of androgen-dependent prostate cells. Pretreatment of rats with nifedipine prior to castration abrogated inducible expression of the par genes, indicating that their expression was downstream to Ca2+ elevation. Further characterization of these genes revealed that induction of par-4 is apoptosis specific: it is not induced by effectors of growth stimulation, oxidative stress and necrosis, or growth arrest in prostate cells. Together, par-1, -3, -4, and -5 represent an apoptosis response gene program common to both androgen-dependent and -independent prostate cells. Thus, cell death programs in prostate cells are comprised of genes specifically associated with apoptosis as well as those with multifunctional roles in growth regulation. Since elevation of intracellular Ca2+ is central to apoptosis in many cell types, we predict that par genes will be important components of diverse effector-driven apoptotic pathways.


This article has been cited by other articles:


Home page
Cancer Res.Home page
N. Hebbar, R. Burikhanov, N. Shukla, S. Qiu, Y. Zhao, K. S. J. Elenitoba-Johnson, and V. M. Rangnekar
A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors
Cancer Res., August 1, 2017; 77(15): 4039 - 4050.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
L. K. SATHERLEY, P.-H. SUN, K. JI, M. MASON, R. HARGEST, W. G. JIANG, and L. YE
Prostate Apoptosis Response-4 (PAR4) Suppresses Growth and Invasion of Breast Cancer Cells and Is Positively Associated with Patient Survival
Anticancer Res, March 1, 2016; 36(3): 1227 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Chaudhry, M. Singh, S. Parent, and E. Asselin
Prostate Apoptosis Response 4 (Par-4), a Novel Substrate of Caspase-3 during Apoptosis Activation
Mol. Cell. Biol., February 15, 2012; 32(4): 826 - 839.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Donninger, L. Hesson, M. Vos, K. Beebe, L. Gordon, D. Sidransky, J. W. Liu, T. Schlegel, S. Payne, A. Hartmann, et al.
The Ras Effector RASSF2 Controls the PAR-4 Tumor Suppressor
Mol. Cell. Biol., June 1, 2010; 30(11): 2608 - 2620.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Acharya, D. J. Lingenfelter, L. Huang, P. J. Gage, and M. A. Walter
Human PRKC Apoptosis WT1 Regulator Is a Novel PITX2-interacting Protein That Regulates PITX2 Transcriptional Activity in Ocular Cells
J. Biol. Chem., December 11, 2009; 284(50): 34829 - 34838.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Boosen, S. Vetterkind, J. Kubicek, K.-H. Scheidtmann, S. Illenberger, and U. Preuss
Par-4 Is an Essential Downstream Target of DAP-like Kinase (Dlk) in Dlk/Par-4-mediated Apoptosis
Mol. Biol. Cell, September 15, 2009; 20(18): 4010 - 4020.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. J. Fernandez-Marcos, S. Abu-Baker, J. Joshi, A. Galvez, E. A. Castilla, M. Canamero, M. Collado, C. Saez, G. Moreno-Bueno, J. Palacios, et al.
Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-{kappa}B activation and invasive prostate carcinoma
PNAS, August 4, 2009; 106(31): 12962 - 12967.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
L. Ye, H. Kynaston, and W. G. Jiang
Bone Morphogenetic Protein-9 Induces Apoptosis in Prostate Cancer Cells, the Role of Prostate Apoptosis Response-4
Mol. Cancer Res., October 1, 2008; 6(10): 1594 - 1606.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. S. Azmi, Z. Wang, R. Burikhanov, V. M. Rangnekar, G. Wang, J. Chen, S. Wang, F. H. Sarkar, and R. M. Mohammad
Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis
Mol. Cancer Ther., September 1, 2008; 7(9): 2884 - 2893.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
J. Joshi, P. J. Fernandez-Marcos, A. Galvez, R. Amanchy, J. F. Linares, A. Duran, P. Pathrose, M. Leitges, M. Canamero, M. Collado, et al.
Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis
EMBO J., August 20, 2008; 27(16): 2181 - 2193.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Goswami, S. Qiu, T. S. Dexheimer, P. Ranganathan, R. Burikhanov, Y. Pommier, and V. M. Rangnekar
Par-4 Binds to Topoisomerase 1 and Attenuates Its DNA Relaxation Activity
Cancer Res., August 1, 2008; 68(15): 6190 - 6198.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. S. Ilkow, V. Mancinelli, M. D. Beatch, and T. C. Hobman
Rubella Virus Capsid Protein Interacts with Poly(A)-Binding Protein and Inhibits Translation
J. Virol., May 1, 2008; 82(9): 4284 - 4294.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. M. Shareef, N. Cui, R. Burikhanov, S. Gupta, S. Satishkumar, S. Shajahan, M. Mohiuddin, V. M. Rangnekar, and M. M. Ahmed
Role of Tumor Necrosis Factor-{alpha} and TRAIL in High-Dose Radiation Induced Bystander Signaling in Lung Adenocarcinoma
Cancer Res., December 15, 2007; 67(24): 11811 - 11820.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhao, R. Burikhanov, S. Qiu, S. M. Lele, C. D. Jennings, S. Bondada, B. Spear, and V. M. Rangnekar
Cancer Resistance in Transgenic Mice Expressing the SAC Module of Par-4
Cancer Res., October 1, 2007; 67(19): 9276 - 9285.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
H. Chung, S. Seo, M. Moon, and S. Park
IGF-I inhibition of apoptosis is associated with decreased expression of prostate apoptosis response-4
J. Endocrinol., July 1, 2007; 194(1): 77 - 85.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Srinivasan, R. S. Ranga, R. Burikhanov, S.-S. Han, and D. Chendil
Par-4-Dependent Apoptosis by the Dietary Compound Withaferin A in Prostate Cancer Cells
Cancer Res., January 1, 2007; 67(1): 246 - 253.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
S. Gao, H. Wang, P. Lee, J. Melamed, C. X Li, F. Zhang, H. Wu, L. Zhou, and Z. Wang
Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland.
J. Mol. Endocrinol., June 1, 2006; 36(3): 463 - 483.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. B. Affar, M. Po-shan Luke, F. Gay, D. Calvo, G. Sui, R. S. Weiss, E. Li, and Y. Shi
Targeted Ablation of Par-4 Reveals a Cell Type-Specific Susceptibility to Apoptosis-Inducing Agents
Cancer Res., April 1, 2006; 66(7): 3456 - 3462.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Goswami, P. Ranganathan, and V. M. Rangnekar
The Phosphoinositide 3-Kinase/Akt1/Par-4 Axis: A Cancer-Selective Therapeutic Target
Cancer Res., March 15, 2006; 66(6): 2889 - 2892.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. Pruitt, A. S. Ulku, K. Frantz, R. J. Rojas, V. M. Muniz-Medina, V. M. Rangnekar, C. J. Der, and J. M. Shields
Ras-mediated Loss of the Pro-apoptotic Response Protein Par-4 Is Mediated by DNA Hypermethylation through Raf-independent and Raf-dependent Signaling Cascades in Epithelial Cells
J. Biol. Chem., June 17, 2005; 280(24): 23363 - 23370.
[Abstract] [Full Text] [PDF]


Home page
EMBO Rep.Home page
I. Garcia-Cao, A. Duran, M. Collado, M. J. Carrascosa, J. Martin-Caballero, J. M. Flores, M. T. Diaz-Meco, J. Moscat, and M. Serrano
Tumour-suppression activity of the proapoptotic regulator Par4
EMBO Rep., June 1, 2005; 6(6): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Gurumurthy, A. Goswami, K. M. Vasudevan, and V. M. Rangnekar
Phosphorylation of Par-4 by Protein Kinase A Is Critical for Apoptosis
Mol. Cell. Biol., February 1, 2005; 25(3): 1146 - 1161.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
E. Bieberich, J. Silva, G. Wang, K. Krishnamurthy, and B. G. Condie
Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants
J. Cell Biol., November 22, 2004; 167(4): 723 - 734.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Kawai, S. Akira, and J. C. Reed
ZIP Kinase Triggers Apoptosis from Nuclear PML Oncogenic Domains
Mol. Cell. Biol., September 1, 2003; 23(17): 6174 - 6186.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. El-Guendy, Y. Zhao, S. Gurumurthy, R. Burikhanov, and V. M. Rangnekar
Identification of a Unique Core Domain of Par-4 Sufficient for Selective Apoptosis Induction in Cancer Cells
Mol. Cell. Biol., August 15, 2003; 23(16): 5516 - 5525.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. K. Cheema, S. K. Mishra, V. M. Rangnekar, A. M. Tari, R. Kumar, and G. Lopez-Berestein
Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter
J. Biol. Chem., May 23, 2003; 278(22): 19995 - 20005.
[Abstract] [Full Text] [PDF]


Home page
EMBO Rep.Home page
I. Garcia-Cao, M. J. Lafuente, L. M. Criado, M. T. Diaz-Meco, M. Serrano, and J. Moscat
Genetic inactivation of Par4 results in hyperactivation of NF-{kappa}B and impairment of JNK and p38
EMBO Rep., March 1, 2003; 4(3): 307 - 312.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Boehrer, K. U. Chow, F. Beske, N. Kukoc-Zivojnov, E. Puccetti, M. Ruthardt, C. Baum, V. M. Rangnekar, D. Hoelzer, P. S. Mitrou, et al.
In Lymphatic Cells Par-4 Sensitizes to Apoptosis by Down-Regulating Bcl-2 and Promoting Disruption of Mitochondrial Membrane Potential and Caspase Activation
Cancer Res., March 1, 2002; 62(6): 1768 - 1775.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Chakraborty, S. G. Qiu, K. M. Vasudevan, and V. M. Rangnekar
Par-4 Drives Trafficking and Activation of Fas and FasL to Induce Prostate Cancer Cell Apoptosis and Tumor Regression
Cancer Res., October 1, 2001; 61(19): 7255 - 7263.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. UNTERGASSER, H. RUMPOLD, E. PLAS, S. MADERSBACHER, and P. BERGER
A low-molecular-weight fraction of human seminal plasma activates adenylyl cyclase and induces caspase 3-independent apoptosis in prostatic epithelial cells by decreasing mitochondrial potential and Bcl-2/Bax ratio
FASEB J, March 1, 2001; 15(3): 673 - 683.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. T. Diaz-Meco and J. Moscat
MEK5, a New Target of the Atypical Protein Kinase C Isoforms in Mitogenic Signaling
Mol. Cell. Biol., February 15, 2001; 21(4): 1218 - 1227.
[Abstract] [Full Text] [PDF]


Home page
EMBO Rep.Home page
J. Moscat and M. T. Diaz-Meco
The atypical protein kinase Cs: Functional specificity mediated by specific protein adapters
EMBO Rep., November 1, 2000; 1(5): 399 - 403.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. D. Beatch and T. C. Hobman
Rubella Virus Capsid Associates with Host Cell Protein p32 and Localizes to Mitochondria
J. Virol., June 15, 2000; 74(12): 5569 - 5576.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
W. A. PEDERSEN, H. LUO, I. KRUMAN, E. KASARSKIS, and M. P. MATTSON
The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis
FASEB J, May 1, 2000; 14(7): 913 - 924.
[Abstract] [Full Text]


Home page
EMBO J.Home page
M. Barradas, A. Monjas, M. T. Diaz-Meco, M. Serrano, and J. Moscat
The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression
EMBO J., November 15, 1999; 18(22): 6362 - 6369.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. Nalca, S. G. Qiu, N. El-Guendy, S. Krishnan, and V. M. Rangnekar
Oncogenic Ras Sensitizes Cells to Apoptosis by Par-4
J. Biol. Chem., October 15, 1999; 274(42): 29976 - 29983.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. T. Diaz-Meco, M.-J. Lallena, A. Monjas, S. Frutos, and J. Moscat
Inactivation of the Inhibitory {kappa}B Protein Kinase/Nuclear Factor {kappa}B Pathway by Par-4 Expression Potentiates Tumor Necrosis Factor {alpha}-induced Apoptosis
J. Biol. Chem., July 9, 1999; 274(28): 19606 - 19612.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. Frutos, J. Moscat, and M. T. Diaz-Meco
Cleavage of {zeta}PKC but Not {lambda}/{iota}PKC by Caspase-3 during UV-induced Apoptosis
J. Biol. Chem., April 16, 1999; 274(16): 10765 - 10770.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Zhu and Z. Wang
Calreticulin Expression Is Associated with Androgen Regulation of the Sensitivity to Calcium Ionophore-induced Apoptosis in LNCaP Prostate Cancer Cells
Cancer Res., April 1, 1999; 59(8): 1896 - 1902.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Sanchez, G. De Carcer, I. V. Sandoval, J. Moscat, and M. T. Diaz-Meco
Localization of Atypical Protein Kinase C Isoforms into Lysosome-Targeted Endosomes through Interaction with p62
Mol. Cell. Biol., May 1, 1998; 18(5): 3069 - 3080.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S.-L. Wu, J. Staudinger, E. N. Olson, and C. S. Rubin
Structure, Expression, and Properties of an Atypical Protein Kinase C (PKC3) from Caenorhabditis elegans: PKC3 IS REQUIRED FOR THE NORMAL PROGRESSION OF EMBRYOGENESIS AND VIABILITY OF THE ORGANISM
J. Biol. Chem., January 9, 1998; 273(2): 1130 - 1143.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
N. R. Murray and A. P. Fields
Atypical Protein Kinase C {iota} Protects Human Leukemia Cells against Drug-induced Apoptosis
J. Biol. Chem., October 31, 1997; 272(44): 27521 - 27524.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
P. Nair, S. Muthukkumar, S. F. Sells, S.-S. Han, V. P. Sukhatme, and V. M. Rangnekar
Early Growth Response-1-dependent Apoptosis Is Mediated by p53
J. Biol. Chem., August 8, 1997; 272(32): 20131 - 20138.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.